THE CONSULT: Rilzabrutinib, Rozanolixizumab, and Beyond: ITP Therapeutics Explored. Professor Paul Klenerman talks to Professor Nichola Cooper about one of her recent papers.

od AoPcasts: "The Consult" Bringing you the latest in medical research